BlueGene Biotech - About the company
BlueGene Biotech is an unfunded company based in Shanghai (China), founded in 2007. It operates as a Manufacturer of reagents and kits. BlueGene Biotech has not raised any funding yet. The company has 719 active competitors, including 48 funded and 88 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Enzo.
Company Details
BlueGene Biotech manufactures and markets a variety of reagents and kits for life sciences industry. The company's product portfolio includes ELISA kits in the area of Cancer, Cardiovascular, Cell Biology, Immunology, Metabolism, Microbiology, Neurobiology, and Signal transduction; Antibodies (Adhesion, Cancer, Cell cycle, Growth factors, Neurobiology, Phosphatases/Kinases, Signal transduction, Transcription); Proteins (Cytokine, Chemokines, Hormone, Enzyme, Ubiquitin), and Plasmids (Full-length, ORF Vectors, Promoters, Reporter genes); and other products such as Stabilizer, Blocking buffer, Dilution buffer, Avidin-HRP, Cell line, and Competent cells.
- Website
- bluegene.cc
- Email ID
- *****@bluegene.cc
- Phone Number
- +86 **********
Key Metrics
Sign up to download BlueGene Biotech's company profile
BlueGene Biotech's funding and investors
BlueGene Biotech has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BlueGene Biotech's Competitors and alternates
Top competitors of BlueGene Biotech include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of BlueGene Biotech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Abcam 1998, Cambridge (United Kingdom), Acquired | Developer of biological reagents for life science research | $78.8M | 76/100 | |
2nd | Meridian Bioscience 1976, Ohio (United States), Acquired | Molecular diagnostic device and kits | - | 65/100 | |
3rd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | - | 60/100 |
4th | Stem Cell Technologies 1993, Vancouver (Canada), Series A | Developer of cell culture media and ancillary reagents for life science research | $11.9M | 58/100 | |
5th | Teknova 1996, Hollister (United States), Public | Provider of molecular biology research reagents and kits | - | 58/100 | |
6th | Cell culture reagents for stem cell research | $18.2M | 55/100 | ||
7th | Cayman Chem 1980, Ann Arbor (United States), Funding Raised | Develops bioreagents and offers preclinical services | - | 54/100 | |
8th |  Huwel Life 2015, Hyderabad (India), Seed | Molecular diagnostic solutions and products for the healthcare industry | $106K | 54/100 | |
9th | PL BioScience 2015, Aachen (Germany), Series A | Manufacturer of human platelet lysate products for cell culture applications | $13M | 53/100 | |
10th | Genetix Biotech 2001, Delhi (India), Unfunded | Provider of kits and reagents for life sciences companies | - | - | 53/100 |
491st | BlueGene Biotech 2007, Shanghai (China), Unfunded | Manufacturer of reagents and kits | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on BlueGene Biotech's competitors? Click here to see the top ones
BlueGene Biotech's Investments and acquisitions
BlueGene Biotech has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about BlueGene Biotech
Explore our recently published companies
- Chiku Cabs - Varanasi based, 2018 founded, Unfunded company
- Chuchuro - 2009 founded, Unfunded company
- Stacyraske - Unfunded company
- Blessitforward - Unfunded company
- Popupkasse - Germany based, Unfunded company
- Vasara - Vilnius based, 2026 founded, Unfunded company
